The TLR3, PI3K, survin, FasL, and Fas genes as major risk factors of occurrence and development of cervical cancer disease
Author:
Publisher
Elsevier BV
Subject
Genetics,General Medicine
Reference32 articles.
1. Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly[I]:poly[C(12)U] (Ampligen R);Adams;Vaccine,2003
2. Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4;Aksoy;Eur. J. Immunol.,2005
3. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma;Ambrosini;Nat. Med.,1997
4. Cancer Facts & Figures 2010;American Cancer Society,2010
5. Chemoprevention and vaccines: a review of the nonsurgical options for the treatment of cervical dysplasia;Bell;Int. J. Gynecol. Cancer,2005
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bioinformatics analysis to identify the relationship between human papillomavirus-associated cervical cancer, toll-like receptors and exomes: A genetic epidemiology study;PLOS ONE;2024-08-29
2. Probing the Effects of Retinoblastoma Binding Protein 6 (RBBP6) Knockdown on the Sensitivity of Cisplatin in Cervical Cancer Cells;Cells;2024-04-18
3. A bioinformatics analysis and an experimental validation of the hypoxia-related prognostic model;Journal of Gastrointestinal Oncology;2023-06
4. Molecular biological mechanism of action in cancer therapies: Juglone and its derivatives, the future of development;Biomedicine & Pharmacotherapy;2022-04
5. Roles of Toll-Like Receptor 3 in Human Tumors;Frontiers in Immunology;2021-04-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3